Literature DB >> 29165208

Case Report: First Coinfection Report of Mixed Leishmania infantum/Leishmania major and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran.

Alireza Badirzadeh1, Mehdi Mohebali2,3, Sadaf Sabzevari4, Majid Ghafoori5, Kourosh Arzamani4, Mohammad Seyyedin6, Seyed Ahmad Hashemi4.   

Abstract

Visceral leishmaniasis, a neglected tropical disease, is the third most common opportunistic disease in immunosuppressed patients, such as those affected by the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome. Although the reports have been characterized as Leishmania/HIV coinfections, the occurrence of a mixed infection by two Leishmania species in HIV-positive patients is rare. Here, we present an atypical case of disseminated cutaneous leishmaniasis (DCL) in a 26-year-old HIV-positive man. The diagnosis of DCL was established using skin biopsy and histopathology examinations and confirmed by molecular techniques. This is the first case of a Leishmania/HIV coinfection due to a mixed infection of Leishmania infantum/Leishmania major in Iran.

Entities:  

Mesh:

Year:  2018        PMID: 29165208      PMCID: PMC5928724          DOI: 10.4269/ajtmh.17-0490

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.

Authors:  S Jafari; M Hajiabdolbaghi; M Mohebali; H Hajjaran; H Hashemian
Journal:  East Mediterr Health J       Date:  2010-03       Impact factor: 1.628

2.  Coinfection of Leishmania guyanensis and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Ecuador.

Authors:  Manuel Calvopina; Cristina Aguirre; William Cevallos; Alberto Castillo; Ibrahim Abbasi; Alon Warburg
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

3.  Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study.

Authors:  Reza Shafiei; Mehdi Mohebali; Behnaz Akhoundi; Meysam Sharifdini Galian; Fathollah Kalantar; Saeedeh Ashkan; Abdolmajid Fata; Bibi Razieh Hosseini Farash; Mehrdad Ghasemian
Journal:  Travel Med Infect Dis       Date:  2013-09-26       Impact factor: 6.211

4.  Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002-2011: a case series.

Authors:  Alireza Badirzadeh; Mehdi Mohebali; Mehrdad Ghasemian; Hassan Amini; Zabiholah Zarei; Behnaz Akhoundi; Homa Hajjaran; Dariush Emdadi; Soheila Molaei; Ahmad Kusha; Saber Alizadeh
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

5.  Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.

Authors:  M Heidari-Kharaji; T Taheri; D Doroud; S Habibzadeh; A Badirzadeh; S Rafati
Journal:  Parasite Immunol       Date:  2016-06-29       Impact factor: 2.280

6.  Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.

Authors:  Leonardo Calza; Antonietta D'Antuono; Ginevra Marinacci; Roberto Manfredi; Vincenzo Colangeli; Beatrice Passarini; Roberto Orioli; Ornella Varoli; Francesco Chiodo
Journal:  J Am Acad Dermatol       Date:  2004-03       Impact factor: 11.527

7.  Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran.

Authors:  Mohammadali Davarpanah; Masumeh Rassaei; Fatemeh Sari Aslani
Journal:  Case Rep Infect Dis       Date:  2015-05-05

Review 8.  Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features.

Authors:  Mehdi Mohebali
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

9.  Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.

Authors:  Alireza Badirzadeh; Tahereh Taheri; Yasaman Taslimi; Zahra Abdossamadi; Maryam Heidari-Kharaji; Elham Gholami; Baharehsadat Sedaghat; Maryam Niyyati; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

10.  Severe Cutaneous Leishmaniasis in a Human Immunodeficiency Virus Patient Coinfected with Leishmania braziliensis and Its Endosymbiotic Virus.

Authors:  Laurent Parmentier; Alexia Cusini; Norbert Müller; Haroun Zangger; Mary-Anne Hartley; Chantal Desponds; Patrik Castiglioni; Patrick Dubach; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Am J Trop Med Hyg       Date:  2016-02-01       Impact factor: 2.345

View more
  5 in total

1.  High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.

Authors:  Z Rezaei; B Sarkari; M Dehghani; A Layegh Gigloo; M Afrashteh
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

2.  Clinico-Hematological Findings of Acute Pediatric Visceral Leishmaniasis Referred to the Northeast of Iran during 2005-2015.

Authors:  Shaghik Barani; Habibollah Turki; Reza Shafiei; Fatemeh Jafarzadeh; Hoda Hosseinzadeh Maleki; Saber Raeghi
Journal:  Iran J Parasitol       Date:  2020 Apr-Jun       Impact factor: 1.012

3.  Super Infection of Cutaneous Leishmaniasis Caused by Leishmania major and L. tropica to Crithidia fasciculata in Shiraz, Iran.

Authors:  Aliyar Mirzapour; Alireza Badirzadeh; Marzieh Ashrafmansouri; Hamed Behniafar; Maryam Norouzi; Hakim Azizi; Mahmoodreza Behravan; Seyyed Javad Seyyed Tabaei
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

Review 4.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16

5.  A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani.

Authors:  Emmanuel Broni; Samuel K Kwofie; Seth O Asiedu; Whelton A Miller; Michael D Wilson
Journal:  Biomolecules       Date:  2021-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.